SCHEMBL1975403

SCHEMBL1975403

N=C(N(N)N)N(N)N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5014874 0.79
SCHEMBL215024 0.70
Water SCHEMBL5014877 0.67
SCHEMBL28150654 0.67
SCHEMBL22844429 0.67
Hydrochloric Acid SCHEMBL442651 0.67
SCHEMBL2152184 0.65
Guanidine SCHEMBL8635661 0.60
SCHEMBL4135863 0.60
SCHEMBL4099773 0.57

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2962991-B1 METHOD FOR PRODUCING CARBON MATERIAL NISSHINBO HOLDINGS INC (JP) 2019-09-18 EP claimed
EP-2962991-B1 METHOD FOR PRODUCING CARBON MATERIAL NISSHINBO HOLDINGS INC (JP) 2019-09-18 EP disclosed
EP-2543661-B1 Guanylhydrazone compounds, compositions, methods of making and using FERRING BV (NL) 2016-12-07 EP disclosed
EP-2962991-A1 CARBON MATERIAL, FUEL CELL, ELECTRICAL DOUBLE-LAYER CAPACITOR, CARBON DIOXIDE ADSORPTION DEVICE, AND CARBON MATERIAL PRODUCTION METHOD Nisshinbo Holdings Inc. (JP) 2016-01-06 EP disclosed
EP-1778265-B1 GUANYLHYDRAZONE COMPOUNDS, COMPOSITIONS, METHODS OF MAKING AND USING FERRING BV (NL) 2013-04-24 EP disclosed
EP-2543661-A1 Guanylhydrazone compounds, compositions, methods of making and using Cytokine Pharmasciences, Inc. (US) 2013-01-09 EP disclosed
US-8247455-B2 Guanylhydrazone compounds, compositions, methods of making and using FERRING B.V. (NL) 2012-08-21 US disclosed
US-20110144189-A1 GUANYLHYDRAZONE COMPOUNDS, COMPOSITIONS, METHODS OF MAKING AND USING CYTOKINE PHARMASCIENCES, INC. (US) 2011-06-16 US disclosed
US-7863334-B2 Guanylhydrazone compounds, compositions, methods of making and using CYTOKINE PHARMASCIENCES, INC. (US) 2011-01-04 US disclosed
US-20080070959-A1 GUANYLHYDRAZONE COMPOUNDS, COMPOSITIONS, METHODS OF MAKING AND USING CYTOKINE PHARMASCIENCES, INC. (US) 2008-03-20 US disclosed
US-7291647-B2 Guanylhydrazone compounds, compositions, methods of making and using CYTOKINE PHARMASCIENCES, INC. (US) 2007-11-06 US disclosed
EP-1778265-A2 GUANYLHYDRAZONE COMPOUNDS, COMPOSITIONS, METHODS OF MAKING AND USING Cytokine Pharmasciences, Inc. (US) 2007-05-02 EP disclosed
WO-2006023586-A2 GUANYLHYDRAZONE COMPOUNDS, COMPOSITIONS, METHODS OF MAKING AND USING CYTOKINE PHARMASCIENCES, INC. (US) 2006-03-02 WO disclosed
US-20060041002-A1 Guanylhydrazone compounds, compositions, methods of making and using FERRING BV (NL) 2006-02-23 US disclosed